Gomekli 82448-0134-42
Generic: Mirdametinib
- Manufacturer
- Springworks Therapeutics, Inc.
- Dosage Form
- Tablet, For Suspension
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- February 11, 2025
- Listing Expires
- December 31, 2027
- Application
- NDA219379
Need to source Gomekli? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Mirdametinib | 1 mg/1 |
Drug Class
Kinase Inhibitor [EPC]Kinase Inhibitor [EPC]Mitogen-Activated Protein Kinase Kinase 1 Inhibitors [MoA]
Selected Package
82448-0134-42Selected42 TABLET, FOR SUSPENSION in 1 BOTTLE (82448-134-42)
Other packages for this product(1)
84 TABLET, FOR SUSPENSION in 1 BOTTLE (82448-134-84)